# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Enlivex Therapeutics (NASDAQ:ENLV) with a Buy and maintains $7...
Enlivex Therapeutics Ltd. (NASDAQ:ENLV, the "Company")))), a clinical-stage macrophage reprogramming immunotherapy com...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex Therapeutics (NASDAQ:ENLV) with a Buy and lowers the pr...
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The D...
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday.